Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL2316454

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
COc1ccc(OCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]2CCNC2=O)C(=O)c2ncc(-c3ccc(Cl)cc3)s2)C(C)C)cc1

Basic Information

ChEMBL ID CHEMBL2316454
Phase Preclinical
Structure Type MOL
InChI Key DXBSWRWNRNLZAM-RONPGKLQSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

726.3
MW (Da)
4.42
ALogP
9
HBA
4
HBD
164.8
PSA (Ų)
0.15
QED
1
Ro5 Violations
17
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C36H44ClN5O7S
MW 726.30
Aromatic Rings 3
Heavy Atoms 50
NP-Likeness -0.36

Activity Summary

Ki 1 meas. best 5.89

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
Ki 5.89 5.89 1300.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked Ki = 1300.0 nM 5.89 Inhibition of SARS coronavirus 3C-like protease R188I mutant using Dabcyl- KTSAV... 23245752

Literature References

PubMed DOI Target Context # Activities
23245752 10.1016/j.bmc.2012.11.017 Unchecked 1

Data from ChEMBL 36 via Core Engine